ArticleParasites, hosts and diseases2026
Nucleolar organization and divergent transcriptional machinery in Giardia lamblia: Structural insights and implications for drug targeting.
Article in Parasites, hosts and diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giardia lamblia is a protozoan parasite responsible for Giardiasis, one of the most prevalent intestinal infections worldwide. Despite its medical relevance, the molecular organization of its transcriptional apparatus remains poorly characterized. Here, I present an integrative analysis of the structural and functional features of the Giardia nucleolus and its transcription machinery. Treatment with actinomycin D induces nucleolar disorganization, confirming active rRNA transcription and nucleolar stress. Additionally, I highlight the highly divergent TATA-binding protein as a potential therapeutic target, given its essential role in transcription and its low mutation rate. Collectively, these findings provide new insights into the minimalist eukaryotic architecture of G. lamblia and identify unique molecular elements that may serve as selective antiparasitic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.